MM

Marie McDonald

Nanosonics Limited | Non-Executive Director
Ms McDonald is a Director of several ASX-listed life science companies including CSL and Nanosonics. She brings experience in financial markets, mergers and acquisitions, regulatory policy, remuneration, risk management and compliance. Ms McDonald practised for 30 years as a commercial lawyer for law firm Ashurst Australia and was previously a long-serving member of the Australia Takeovers Panel.

Companies and Roles

Company
Title
Tenure
Since
NAN
Nanosonics Limited
  • Non-Executive Director
8yrs, 7mthOct 2016
NUF
Nufarm Limited
  • Non-Executive Director
8yrs, 2mthMar 2017
TLX
Telix Pharmaceuticals Limited
  • Non-Executive Director
3mthMar 2025
CSL
CSL Limited
  • Non-Executive Director
11yrs, 10mthAug 2013

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TLX
Telix Pharmaceuticals Limited
05/03/2503,719N/AN/A
CSL
CSL Limited
19/02/2504,369N/AN/A
NUF
Nufarm Limited
30/09/24N/A45,179N/AN/A
NAN
Nanosonics Limited
30/06/2418,60631,500N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TLX
Telix Pharmaceuticals Limited
05/03/25
Buy
3,719$26.910$100,078On-market trade
CSL
CSL Limited
19/02/25
Buy
88$264.841$23,306Conversion of securities
CSL
CSL Limited
19/02/25
Exercise
88$264.841$23,306Conversion of securities
CSL
CSL Limited
21/08/24
Issued
176$304.080$53,518Director remuneration
CSL
CSL Limited
16/08/24
Buy
145$305.338$44,274Conversion of securities